• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[引入麻疹、腮腺炎和风疹(MMR)疫苗接种后至2002年期间MMR免疫力的变化]

[Changes in measles, mumps and rubella (MMR) immunity until the year of 2002 after the introduction of MMR vaccination].

作者信息

Rønne T, Trier H

机构信息

Epidemiologisk afdeling, Statens Seruminstitut, København.

出版信息

Ugeskr Laeger. 1992 Jul 13;154(29):2014-8.

PMID:1509567
Abstract

In order to decide whether vaccination for measles, mumps and rubella should be introduced at the age of five years, calculations of the immunities in various age groups were performed until the year 2002 with and without vaccination at the age of five years. These calculations are based on the knowledge of immunity in the various age groups before the MMR vaccination programme was instituted in 1987 and knowledge of the compliance with vaccination obtained to date. Future predictions reveal that it is of decisive significance that compliance with vaccination among 12-year-olds is increased as rapidly as possible to 0.7 and to 0.8 in the subsequent year, if the level of immunity present prior to institution of the vaccination programme is to be maintained. The second vaccination given at a shorter interval after the first would prevent about 150 cases of illness in all per annum among 6-12 years-old. However, this should not be introduced at the expense of vaccination at the age of 12 years, which should be continued for at least 10-15 years yet. Possible abandoning of vaccination at the age of 12 years 10-15 years hence presupposes that adequate numbers of the children have been vaccinated twice at an early age and that it is sufficiently certain that secondary failure of vaccination does not occur to any significant extent.

摘要

为了决定是否应在五岁时引入麻疹、腮腺炎和风疹疫苗接种,对不同年龄组在2002年之前无论是否进行五岁时疫苗接种的免疫力进行了计算。这些计算基于1987年实施麻疹、腮腺炎和风疹联合疫苗(MMR)接种计划之前各年龄组的免疫情况以及迄今获得的疫苗接种依从性知识。未来预测表明,如果要维持疫苗接种计划实施前的免疫水平,至关重要的是尽快将12岁儿童的疫苗接种依从性提高到0.7,并在次年提高到0.8。在首次接种后较短间隔内进行第二次接种,每年可在6至12岁儿童中预防约150例发病。然而,这不应以牺牲12岁时的疫苗接种为代价,12岁时的疫苗接种应至少持续10至15年。10至15年后可能放弃12岁时的疫苗接种,前提是足够数量的儿童在幼年时已接种两次疫苗,并且有足够把握确保不会出现显著程度的疫苗接种继发失败。

相似文献

1
[Changes in measles, mumps and rubella (MMR) immunity until the year of 2002 after the introduction of MMR vaccination].[引入麻疹、腮腺炎和风疹(MMR)疫苗接种后至2002年期间MMR免疫力的变化]
Ugeskr Laeger. 1992 Jul 13;154(29):2014-8.
2
[Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].[1996年麻疹、腮腺炎和风疹抗体的年龄相关血清流行率]
Schweiz Med Wochenschr. 1998 Apr 25;128(17):649-57.
3
[Duration of immunity and occurrence of secondary vaccine failure following vaccination against measles, mumps and rubella].[麻疹、腮腺炎和风疹疫苗接种后的免疫持续时间及二次疫苗失败情况]
Ugeskr Laeger. 1992 Jul 13;154(29):2008-13.
4
Prevalence of IgG-antibodies to mumps and measles virus in non-vaccinated children.未接种疫苗儿童中针对腮腺炎病毒和麻疹病毒的IgG抗体流行率。
Dan Med Bull. 1988 Apr;35(2):185-7.
5
Response to measles, mumps and rubella vaccine in paediatric bone marrow transplant recipients.儿科骨髓移植受者对麻疹、腮腺炎和风疹疫苗的反应。
Bone Marrow Transplant. 1996 Apr;17(4):633-6.
6
Evaluation of a combined measles-mumps-rubella-chickenpox vaccine.一种麻疹-腮腺炎-风疹-水痘联合疫苗的评估
Dev Biol Stand. 1986;65:85-8.
7
Seroepidemiological study of measles after the 1992 nationwide MMR revaccination program in Taiwan.台湾1992年全国性麻疹、腮腺炎、风疹联合疫苗再接种计划后的麻疹血清流行病学研究。
J Med Virol. 1997 Jan;51(1):32-5.
8
[Mumps epidemic in vaccinated children in West Switzerland].[瑞士西部接种疫苗儿童中的腮腺炎疫情]
Schweiz Med Wochenschr. 1997 Jun 28;127(26):1124-33.
9
Immunity to and immunization against measles, rubella and mumps in patients after autologous bone marrow transplantation.自体骨髓移植患者对麻疹、风疹和腮腺炎的免疫及免疫接种情况。
Bone Marrow Transplant. 1992 Jun;9(6):427-32.
10
Antibody persistence after primary measles-mumps-rubella vaccine and response to a second dose given at four to six vs. eleven to thirteen years.初次接种麻疹-腮腺炎-风疹疫苗后的抗体持久性以及在4至6岁与11至13岁时接种第二剂疫苗后的反应。
Pediatr Infect Dis J. 1996 Aug;15(8):687-92. doi: 10.1097/00006454-199608000-00010.